Evaluation of the Latella™ Knee Implant System for Medial Osteoarthritis Pain Reduction

ClinicalTrials.gov ID: NCT02608957

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02608957. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Latella™ Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-US Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the Latella-US study is to demonstrate the safety and efficacy of the Latella Knee Implant System for the reduction of medial osteoarthritis pain.

Study identification

NCT ID: NCT02608957
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Cotera, Inc.; Industry
Enrollment: 1 participant

Conditions and interventions

Conditions

Osteoarthritis

Interventions

Latella Knee Implant System Device

Device

Eligibility (public fields only)

Age range: 30 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2015 (Actual)
Primary completion: May 2016 (Actual)
Completion: Mar 2017 (Actual)
Last update posted: Apr 4, 2017

2015 – 2017

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
The George Washington University	Washington D.C.	District of Columbia	20037	—
Rush University Medical Center	Chicago	Illinois	60612	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02608957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 4, 2017 · Synced Nov 14, 2026